Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1–SIRT1–PGC-1α

Qi Guo,Bo Chang,Qiong-li Yu,Si-tong Xu,Xue-jie Yi,Shi-cheng Cao
DOI: https://doi.org/10.1007/s00125-020-05269-3
IF: 8.2
2020-09-03
Diabetologia
Abstract:Adiponectin stimulates mitochondrial biogenesis through peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α), a major regulator of mitochondrial biogenesis. MOTS-c (mitochondrial open reading frame of the 12S rRNA) is a biologically active mitochondrial-derived peptide encoded by mitochondrial DNA. It influences the mechanisms of obesity and diabetes. We hypothesised that the adiponectin pathway may regulate the production and/or secretion of MOTS-c in skeletal muscle. We aimed to determine whether exercise and adiponectin affect MOTS-c to improve insulin resistance in mice.
endocrinology & metabolism
What problem does this paper attempt to address?
The paper aims to address the following key issues: 1. **Regulatory Mechanism Exploration**: The study investigates whether adiponectin regulates the production and secretion of MOTS-c in skeletal muscle cells by increasing the levels of APPL1, SIRT1, and PGC-1α. MOTS-c is a bioactive peptide encoded by mitochondrial DNA, which is related to the mechanisms of obesity and diabetes. 2. **Exercise Stimulation Effect**: The research also explores whether exercise can stimulate the production of MOTS-c in skeletal muscle, thereby increasing the systemic levels of MOTS-c in the body and improving insulin resistance. Through the above studies, the paper provides new insights into the cellular and molecular pathways involved in the pathogenesis of diabetes and suggests that MOTS-c may become a potential new target for diabetes treatment.